Solid Tumors: E7386 with Other Anticancer Drugs

We are studying the safety and effectiveness of E7386 combined with other anticancer treatments for patients with solid tumors. This trial aims to find the best dose and assess how well it works compared to standard therapies.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Doxorubicin Ebewe
Doxorubicin Ebewe is a chemotherapy medicine used to treat many different types of cancer.
Doxorubicina Aurobindo
Doxorubicina Aurobindo is a chemotherapy medicine used to treat various types of cancer.
Lenvima
Lenvima is a cancer medicine used to treat certain types of thyroid, liver, and kidney cancers.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Doxorubicin
Doxorubicin is a chemotherapy substance used to treat various cancers by killing rapidly dividing cancer cells.
Doxorubicin Hydrochloride
Doxorubicin hydrochloride is a chemotherapy substance used to treat various cancers by killing or slowing the growth of cancer cells.
Lenvatinib
Lenvatinib is a substance that helps treat certain types of cancer by blocking signals tumors use to grow and spread.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

E7386
(6s,9as)-8-((6-(3-(4-ethyl-1-piperazinyl)-1-azetidinyl)-2-pyridinyl)methyl)-6-((2-fluoro-4-hydroxyphenyl)methyl)hexahydro-4

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Abutrax
Abutrax
Adriacept Blasen-Instillations-Set

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Rigshospitalet
Department of Oncology
Copenhagen, Denmark
Odense University Hospital
Department of Oncology
Odense, Denmark
Institut De Cancerologie De L Ouest
Medical oncology
Avignon, France

Sponsor: Eisai Limited
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.